Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias

Advances in Hematology

Volumn 2010, Issue , 2010, Pages

  Nemeth, Elizabeta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERROPORTIN; HEPCIDIN; HEPCIDIN AGONIST; HEPCIDIN ANTAGONIST; IRON; UNCLASSIFIED DRUG;

ANEMIA; BETA THALASSEMIA; CHRONIC KIDNEY DISEASE; HUMAN; INFLAMMATION; INTESTINE CELL; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION;

EID: 77953372800     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2010/750643     Document Type: Review

References (74)

1. Park C. H., Valore E. V., Waring A. J., Ganz T., Hepcidin, a urinary antimicrobial peptide synthesized in the liver Journal of Biological Chemistry 2001 276 11 7806 7810 (Pubitemid 37385573)
2. Gagliardo B., Kubat N., Faye A., Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process Journal of Hepatology 2009 50 2 394 401
3. Valore E. V., Ganz T., Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin Blood Cells, Molecules, and Diseases 2008 40 1 132 138 (Pubitemid 350192311)
4. Roy C. N., Mak H. H., Akpan I., Losyev G., Zurakowski D., Andrews N. C., Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation Blood 2007 109 9 4038 4044 (Pubitemid 46641759)
5. Roettol A., Papanikolaou G., Politou M., Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis Nature Genetics 2003 33 1 21 22 (Pubitemid 36068676)
6. Donovan A., Lima C. A., Pinkus J. L., The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis Cell Metabolism 2005 1 3 191 200 (Pubitemid 43960600)
7. Abboud S., Haile D. J., A novel mammalian iron-regulated protein involved in intracellular iron metabolism Journal of Biological Chemistry 2000 275 26 19906 19912 (Pubitemid 30441595)
8. Donovan A., Brownlie A., Zhou Y., Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter Nature 2000 403 6771 776 781 (Pubitemid 30111839)
9. McKie A. T., Marciani P., Rolfs A., A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation Molecular Cell 2000 5 2 299 309 (Pubitemid 30628088)
10. Nemeth E., Tuttle M. S., Powelson J., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 2004 306 5704 2090 2093 (Pubitemid 40007660)
11. Rivera S., Nemeth E., Gabayan V., Lopez M. A., Farshidi D., Ganz T., Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs Blood 2005 106 6 2196 2199 (Pubitemid 41291740)
12. Zhang D.-L., Hughes R. M., Ollivierre-Wilson H., Ghosh M. C., Rouault T. A., A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression Cell Metabolism 2009 9 5 461 473
13. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M., Immunoassay for human serum hepcidin Blood 2008 112 10 4292 4297
14. Pak M., Lopez M. A., Gabayan V., Ganz T., Rivera S., Suppression of hepcidin during anemia requires erythropoietic activity Blood 2006 108 12 3730 3735 (Pubitemid 44864551)
15. Ganz T., Molecular pathogenesis of anemia of chronic disease Pediatric Blood and Cancer 2006 46 5 554 557
16. Xia Y., Babitt J. L., Sidis Y., Chung R. T., Lin H. Y., Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin Blood 2008 111 10 5195 5204
17. Andriopoulos B. Jr., Corradini E., Xia Y., BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism Nature Genetics 2009 41 4 482 487
18. Meynard D., Kautz L., Darnaud V., Canonne-Hergaux F., Coppin H., Roth M.-P., Lack of the bone morphogenetic protein BMP6 induces massive iron overload Nature Genetics 2009 41 4 478 481
19. Babitt J. L., Huang F. W., Wrighting D. M., Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression Nature Genetics 2006 38 5 531 539
20. Lin L., Goldberg Y. P., Ganz T., Competitive regulation of hepcidin mRNAby soluble and cell-associated hemojuvelin Blood 2005 106 8 2884 2889 (Pubitemid 41510769)
21. Niederkofler V., Salie R., Arber S., Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload Journal of Clinical Investigation 2005 115 8 2180 2186 (Pubitemid 41134159)
22. Silvestri L., Pagani A., Nai A., de Domenico I., Kaplan J., Camaschella C., The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin Cell Metabolism 2008 8 6 502 511
23. Zhang A.-S., Yang F., Meyer K., Neogenin-mediated hemojuvelin shedding occurs after hemojuvelin traffics to the plasma membrane Journal of Biological Chemistry 2008 283 25 17494 17502
24. Kautz L., Meynard D., Monnier A., Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver Blood 2008 112 4 1503 1509
25. Johnson M. B., Chen J., Murchison N., Green F. A., Enns C. A., Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway Molecular Biology of the Cell 2007 18 3 743 754 (Pubitemid 46399482)
26. Ramey G., Deschemin J.-C., Vaulont S., Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes Haematologica 2009 94 6 765 772
27. Goswami T., Andrews N. C., Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing Journal of Biological Chemistry 2006 281 39 28494 28498 (Pubitemid 44506991)
28. Piperno A., Girelli D., Nemeth E., Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis Blood 2007 110 12 4096 4100 (Pubitemid 350248467)
29. Ashby D. R., Gale D. P., Busbridge M, Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica. In press
30. Huang H., Constante M., Layoun A., Santos M. M., Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli Blood 2009 113 15 3593 3599
31. Vokurka M., Krijt J., Sulc K., Necas E., Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis Physiological Research 2006 55 6 667 674 (Pubitemid 46021227)
32. Tanno T., Bhanu N. V., Oneal P. A., High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin Nature Medicine 2007 13 9 1096 1101 (Pubitemid 47517510)
33. Tanno T., Porayette P., Sripichai O., Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells Blood 2009 114 1 181 186
34. Peyssonnaux C., Zinkernagel A. S., Schuepbach R. A., Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs) Journal of Clinical Investigation 2007 117 7 1926 1932 (Pubitemid 47036326)
35. Semrin G., Fishman D. S., Bousvaros A., Impaired intestinal iron absorption in Crohns disease correlates with disease activity and markers of inflammation Inflammatory Bowel Diseases 2006 12 12 1101 1106 (Pubitemid 44847466)
36. Sharma S., Nemeth E., Chen Y.-H., Involvement of hepcidin in the anemia of multiple myeloma Clinical Cancer Research 2008 14 11 3262 3267
37. Nemeth E., Valore E. V., Territo M., Schiller G., Lichtenstein A., Ganz T., Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 2003 101 7 2461 2463 (Pubitemid 36857598)
38. Verga Falzacappa M. V., Vujic Spasic M., Kessler R., Stolte J., Hentze M. W., Muckenthaler M. U., STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation Blood 2007 109 1 353 358 (Pubitemid 46053077)
39. Nemeth E., Rivera S., Gabayan V., IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin Journal of Clinical Investigation 2004 113 9 1271 1276 (Pubitemid 39069926)
40. Rivera S., Gabayan V., Ganz T., In chronic inflammation, there exists an IL-6 independent pathway for the induction of hepcidin 2004 104 11. Abstract no. 3205
41. Peyssonnaux C., Zinkernagel A. S., Datta V., Lauth X., Johnson R. S., Nizet V., TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens Blood 2006 107 9 3727 3732
42. Sazawal S., Black R. E., Ramsan M., Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial The Lancet 2006 367 9505 133 143 (Pubitemid 43077129)
43. Melis M. A., Cau M., Congiu R., A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron Haematologica 2008 93 10 1473 1479
44. Finberg K. E., Heeney M. M., Campagna D. R., Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) Nature Genetics 2008 40 5 569 571
45. Chambers J. C., Zhang W., Li Y., Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels Nature Genetics 2009 41 11 1170 1172
46. Benyamin B., Ferreira M. A. R., Willemsen G., Common variants in TMPRSS6 are associated with iron status and erythrocyte volume Nature Genetics 2009 41 11 1173 1175
47. Weinstein D. A., Roy C. N., Fleming M. D., Loda M. F., Wolfsdorf J. I., Andrews N. C., Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease Blood 2002 100 10 3776 3781
48. Chung A. Y. F., Leo K. W., Wong G. C., Chuah K. L., Ren J. W., Lee C. G. L., Giant hepatocellular adenoma presenting with chronic iron deficiency anemia American Journal of Gastroenterology 2006 101 9 2160 2162
49. Kearney S. L., Nemeth E., Neufeld E. J., Urinary hepcidin in congenital chronic anemias Pediatric Blood and Cancer 2007 48 1 57 63 (Pubitemid 44871594)
50. Nemeth E., Ganz T., Hepcidin and iron-loading anemias Haematologica 2006 91 6 727 732 (Pubitemid 44014536)
51. Origa R., Galanello R., Ganz T., Liver iron concentrations and urinary hepcidin in -thalassemia Haematologica 2007 92 5 583 588 (Pubitemid 350144260)
52. Cartwright G. E., The anemia of chronic disorders Seminars in Hematology 1966 3 4 351 375
53. Rivera S., Liu L., Nemeth E., Gabayan V., Sorensen O. E., Ganz T., Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia Blood 2005 105 4 1797 1802 (Pubitemid 40223704)
54. Li H., Rose M. J., Tran L., Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS Journal of Pharmacological and Toxicological Methods 2009 59 3 171 180
55. Kemna E. H. J. M., Tjalsma H., Podust V. N., Swinkels D. W., Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications Clinical Chemistry 2007 53 4 620 628 (Pubitemid 46580231)
56. Tussing-Humphreys L. M., Liang H., Nemeth E., Freels S., Braunschweig C. A., Excess adiposity, inflammation, and iron-deficiency in female adolescents Journal of the American Dietetic Association 2009 109 2 297 302
57. Tussing-Humphreys L. M., Nemeth E., Fantuzzi G., Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity. In press
58. Sasu B. J., Hainu M., Boone T. C., Hepcidin, hepcidin antagonists and methods of use. US patent no. US2008213277, Amgen Inc.Thousand Oaks, Calif, USA, September 2008
59. Young B., Zaritsky J., Hepcidin for clinicians Clinical Journal of the American Society of Nephrology 2009 4 8 1384 1387
60. Zaritsky J., Young B., Wang H. J., Hepcidina potential novel biomarker for iron status in chronic kidney disease Clinical Journal of the American Society of Nephrology 2009 4 6 1051 1056
61. Ashby D. R., Gale D. P., Busbridge M., Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease Kidney International 2009 75 9 976 981
62. Adamson J. W., Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation Advances in Chronic Kidney Disease 2009 16 2 76 82
63. Elliott J., Mishler D., Agarwal R., Hyporesponsiveness to erythropoietin: causes and management Advances in Chronic Kidney Disease 2009 16 2 94 100
64. Busbridge M., Griffiths C., Ashby D. R., Development of a novel immunoassay for the iron regulatory peptide hepcidin British Journal of Biomedical Science 2009 66 3 150 157
65. Castagna A., Campostrini N., Zaninotto F., Girelli D., Hepcidin assay in serum by SELDI-TOF-MS and other approaches. Journal of Proteomics. In press
66. Bansal S. S., Halket J. M., Fusova J., Quantification of hepcidin using matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry Rapid Communications in Mass Spectrometry 2009 23 11 1531 1542
67. Kroot J. J. C., Hendriks J. C. M., Laarakkers C. M. M., (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies Analytical Biochemistry 2009 389 2 124 129
68. Young M. F., Glahn R. P., Ariza-Nieto M., Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women American Journal of Clinical Nutrition 2009 89 2 533 538
69. Ruivard M., Laine F., Ganz T., Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin Journal of Hepatology 2009 50 6 1219 1225
70. Yu P. B., Hong C. C., Sachidanandan C., Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism Nature Chemical Biology 2008 4 1 33 41 (Pubitemid 350273653)
71. Babitt J. L., Huang F. W., Xia Y., Sidis Y., Andrews N. C., Lin H. Y., Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance Journal of Clinical Investigation 2007 117 7 1933 1939 (Pubitemid 47036327)
72. Nishimoto N., Kanakura Y., Aozasa K., Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease Blood 2005 106 8 2627 2632 (Pubitemid 41510733)
73. Kawabata H., Tomosugi N., Kanda J., Tanaka Y., Yoshizaki K., Uchiyama T., Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castlemans disease Haematologica 2007 92 6 857 858 (Pubitemid 350155317)
74. Klaus S., Arend M., Fourney P., Induction of erythropoiesis and iron utilization by the HIF prolyl hydroxylase inhibitor FG-4592 Journal of the American Society of Nephrology 2005 16 49A